Vodič za dijagnostikovanje i lečenje raka grlića materice - Institut za ...

75. Benedetti-Panici P, Angioli R, Palaia I, Muzii L, Zullo MA, Manci N, Rabitti C.Tailoring
the parametrectomy in stages IA2-IB1 cervical carcinoma: is it feasibleand safe?
Gynecol Oncol. 2005;96:792-8.
76. Landoni F, Maneo A, Cormio G et al. Class II ves Class III radical hysterectomy in
stage Ib-IIa cervical cancer: a prospective randomized study. Gynecol Oncol, 2001;
80: 3-12
77. Querleu D, Morrow CP, Classification of radical hysterectomy. Lancet Oncol 2008;
9:297-303 & Gynecol Oncol 2009; 115:314-315
78. Trimbos JB, Maas CP, Deruiter MC, Peters AAW and Kenter GG. “ A nerve-sparing
radical hysterectomy: guidelines and feasibility in western patients”. Int J Gynecol
Cancer 2001; 11: 180-186,.
79. Sedlis A, Bundy BN, Rotman MZ: A randomized trial of pelvic radiation vesus no
further therapy in selected patients with stage Ib cancer of the cervix after radical
hysterectomy and pelvic lymphadenectomy. Gyn Oncol, 1999; 73: 177-83
80. Prapaporn Suprasert a, , Kittipat Charoenkwan a, Surapan Khunamornpong.
Pelvic node removal and disease-free survival in cervical cancer patients treated with
radical hysterectomy and pelvic lymphadenectomyInternational Journal of
Gynecology and Obstetrics 116 (2012) 43 – 46
81. Verleye L, Vergote I, Reed N, Ottevanger PB. Quality assurance for radical hysterectomy
for cervical cancer: the view of the European Organization for Research and
Treatment of Cancer –Gynecological Cancer Group (EORTC-GCG). Ann Oncol
2009;20(10):1631 – 8.
82. Frumowitz M, Ramirez PT, Levenback C. Lymphatic mapping and sentinel node
dissection in gynecologic malignanices of the lower genital tract. Curr Oncol Rep,
2005; 7: 435-43
83. Eriksson LR, Covens A. Snetinel lymphnode mapping in cervical cancer: the future?
BJOG, 2012; 119:129-133
84. Steed H, Rosen B, Murphy J, Laframboise S, De Petrillo D, Covens A.
A comparison of laparascopic-assisted radical vaginal hysterectomy and radical
abdominal hysterectomy in the treatment of cervical cancer. Gynecol Oncol. 2004;
93:588-93
85. Schneider A, Erdemoglu E, Chiantera V, Reed N, Morice P, Rodolais A, Denschlag
D, Kesic V. Clinical Recommendation Radical Trachelecotmy for fertility Preservation
in Patients With Early-Stage Cervical Cancer. Int J Gynaecol. Cancer, 2012; 22:659-
666
86. Plante M. Vaginal radical trachelectomy: an update. Gynecologic oncology.
2008;111(2 Suppl):S105-10
87. Woo YL, Kyrgiou M, Bryant A, Everett T, Dickinson HO. Centralisation of services for
gynaecological cancer. Cochrane Database of Systematic Reviews 2012, Issue 3.
Art. No.: CD007945. DOI: 10.1002/14651858.CD007945.pub2.
88. Wright JD, Lewin SN, Deutsch I, Burke WM, Sun X, Herzog TJ. The influence of
surgical volume on morbidity and mortality of radical hysterectomy for cervical cancer
Am J Obstet Gynecol. 2011 Sep;205(3):225.e1-7.
89. Maneo A, Chiari S, Bonazzi C, Mangioni C. Neoadjuvant chemotherapy and
conservative surgery for stage IB1 cervical cancer. Gynecologic oncology.
2008;111(3):438-43
90. Robova H, Pluta M, Hrehorcak M, Skapa P, Rob L. High-dose density chemotherapy
followed by simple trachelectomy: full-term pregnancy. International journal of
gynecological cancer, 2008; 18:1367-71.
91. Landoni F, Parma G, Peiretti M, et al. Chemo-conization in early cervical cancer.
Gynecologic oncology. 2007;107(1 Suppl 1):S125-6.
92. Denschlag D, Gabriel B, Mueller-Lantzsch C, Tempfer C, Henne K, Gitsch G,
Hasenburg A.Evaluation of patients after extraperitoneal lymph node dissection for
cervical cancer. Gynecol Oncol. 2005;96:658-64.
72